Double maintains 1 strategies that include PRLB - Proto Labs, Inc.
Current Value
$39.881 Year Return
Current Value
$39.881 Year Return
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| PRNT | 64.26% | $77.58M | 0.66% |
| IWO | 58.98% | $11.53B | 0.24% |
| VTWO | 58.46% | $12.58B | 0.07% |
| IWM | 58.38% | $63.18B | 0.19% |
| PSC | 58.24% | $749.89M | 0.38% |
| PRFZ | 58.05% | $2.36B | 0.34% |
| DFAS | 58.04% | $10.21B | 0.27% |
| GSSC | 57.98% | $560.96M | 0.2% |
| SLYG | 57.98% | $3.40B | 0.15% |
| SCHA | 57.91% | $17.26B | 0.04% |
| IJT | 57.88% | $6.06B | 0.18% |
| ESML | 57.37% | $1.84B | 0.17% |
| IWC | 57.36% | $817.74M | 0.6% |
| ISCG | 57.33% | $679.46M | 0.06% |
| IJR | 57.25% | $79.19B | 0.06% |
| SMMD | 57.24% | $1.45B | 0.15% |
| SPSM | 57.04% | $11.31B | 0.03% |
| VIOO | 56.88% | $2.87B | 0.1% |
| TPSC | 56.81% | $205.43M | 0.52% |
| NUSC | 56.73% | $1.14B | 0.31% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BGRN | 0.07% | $402.97M | 0.2% |
| ICSH | 0.10% | $6.03B | 0.08% |
| IBDX | 0.12% | $1.12B | 0.1% |
| MUST | -0.13% | $438.88M | 0.23% |
| BSCP | -0.14% | $3.28B | 0.1% |
| IGIB | -0.17% | $15.39B | 0.04% |
| VCIT | -0.22% | $54.69B | 0.03% |
| LEMB | 0.28% | $343.71M | 0.3% |
| MUB | -0.29% | $38.56B | 0.05% |
| IBMR | 0.33% | $255.40M | 0.18% |
| BSCU | -0.34% | $1.64B | 0.1% |
| HYMB | 0.36% | $2.62B | 0.35% |
| CGCP | -0.36% | $5.15B | 0.34% |
| UNG | 0.42% | $388.31M | 1.06% |
| SPIB | 0.47% | $10.00B | 0.04% |
| BSCT | 0.49% | $2.10B | 0.1% |
| MINO | -0.56% | $319.43M | 0.39% |
| EMLC | 0.58% | $3.34B | 0.3% |
| KCCA | -0.60% | $105.90M | 0.87% |
| IBDU | -0.78% | $2.68B | 0.1% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TILE | 73.51% | $1.26B | +45.46% | 0.19% |
| ALG | 66.66% | $2.69B | +32.38% | 0.51% |
| WAT | 63.27% | $21.25B | +25.50% | 0.00% |
| TEAM | 59.17% | $54.68B | +13.95% | 0.00% |
| LECO | 57.94% | $11.74B | +13.39% | 1.41% |
| BTSG | 57.62% | $3.92B | +100.63% | 0.00% |
| ECVT | 57.39% | $892.25M | -14.41% | 0.00% |
| CTS | 56.88% | $1.29B | -12.09% | 0.37% |
| AMZN | 56.01% | $2.34T | +10.23% | 0.00% |
| WSC | 55.75% | $5.18B | -23.28% | 0.49% |
| COHU | 55.11% | $912.85M | -41.28% | 0.00% |
| GTLS | 54.85% | $7.31B | +14.16% | 0.00% |
| KWR | 54.82% | $2.10B | -29.42% | 1.59% |
| CVCO | 54.59% | $3.66B | +33.35% | 0.00% |
| IVZ | 54.53% | $7.24B | +7.80% | 5.06% |
| EVR | 54.27% | $10.69B | +30.79% | 1.18% |
| SANM | 53.75% | $5.27B | +50.05% | 0.00% |
| KN | 53.42% | $1.54B | +3.74% | 0.00% |
| MOG.A | 53.29% | $5.75B | +8.38% | 0.63% |
| ITT | 53.04% | $12.48B | +25.04% | 0.84% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| FE | -0.01% | $23.31B | +5.57% | 4.29% |
| ADC | -0.07% | $8.01B | +17.77% | 4.18% |
| EGO | 0.14% | $4.18B | +37.38% | 0.00% |
| DRD | -0.18% | $1.15B | +55.76% | 2.05% |
| GSK | 0.27% | $78.84B | +1.94% | 4.17% |
| SRRK | 0.28% | $3.21B | +342.46% | 0.00% |
| K | 0.35% | $27.71B | +40.85% | 2.85% |
| PEP | -0.41% | $185.45B | -17.31% | 4.04% |
| WTRG | 0.42% | $10.56B | +1.65% | 3.49% |
| CREG | 0.49% | $5.66M | -79.19% | 0.00% |
| BTI | -0.50% | $102.21B | +50.27% | 6.54% |
| DFDV | -0.55% | $309.70M | +2,106.40% | 0.00% |
| MSIF | 0.60% | $756.27M | +33.83% | 7.70% |
| KMB | -0.68% | $43.67B | -4.62% | 3.76% |
| CYCN | 0.75% | $9.95M | +33.33% | 0.00% |
| VHC | -0.78% | $48.79M | +87.46% | 0.00% |
| PHYS.U | 0.79% | - | - | 0.00% |
| ASPS | -0.88% | $99.18M | -12.89% | 0.00% |
| NEUE | 0.88% | $61.16M | +29.25% | 0.00% |
| GFI | 0.96% | $21.24B | +58.84% | 2.32% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -45.64% | $99.49M | 0.59% |
| BTAL | -42.39% | $295.67M | 1.43% |
| VIXY | -40.64% | $165.58M | 0.85% |
| SPTS | -27.68% | $5.77B | 0.03% |
| IVOL | -26.65% | $348.25M | 1.02% |
| UTWO | -26.23% | $379.27M | 0.15% |
| VGSH | -26.19% | $22.77B | 0.03% |
| SCHO | -25.89% | $11.46B | 0.03% |
| XONE | -25.61% | $585.85M | 0.03% |
| IBTG | -25.49% | $1.92B | 0.07% |
| IBTH | -24.55% | $1.60B | 0.07% |
| IBTI | -24.07% | $1.06B | 0.07% |
| IEI | -23.77% | $15.41B | 0.15% |
| FXY | -22.91% | $820.31M | 0.4% |
| IBTJ | -22.85% | $684.86M | 0.07% |
| IBTK | -22.62% | $441.97M | 0.07% |
| IBTM | -22.47% | $315.47M | 0.07% |
| VGIT | -22.36% | $31.79B | 0.04% |
| SPTI | -22.30% | $8.80B | 0.03% |
| FTSD | -22.11% | $231.68M | 0.25% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -23.16% | $24.29B | +35.36% | 1.09% |
| ED | -17.83% | $36.31B | +13.27% | 3.35% |
| SO | -16.27% | $101.44B | +19.02% | 3.16% |
| AEP | -15.31% | $55.76B | +19.14% | 3.55% |
| EXC | -15.09% | $43.82B | +25.72% | 3.63% |
| DUK | -14.22% | $92.39B | +19.10% | 3.55% |
| CME | -13.23% | $99.25B | +39.75% | 3.87% |
| AWK | -12.87% | $27.80B | +10.98% | 2.21% |
| OHI | -12.82% | $10.61B | +8.08% | 7.30% |
| AMT | -12.02% | $105.08B | +16.75% | 2.96% |
| FTS | -10.22% | $23.99B | +23.37% | 3.67% |
| MKTX | -9.19% | $8.37B | +15.12% | 1.35% |
| SBRA | -8.61% | $4.35B | +18.37% | 6.56% |
| MO | -8.42% | $97.93B | +26.25% | 6.95% |
| PPL | -8.08% | $25.13B | +23.96% | 3.15% |
| FDP | -7.11% | $1.59B | +50.47% | 3.29% |
| TU | -6.84% | $24.83B | +9.19% | 7.12% |
| PM | -6.77% | $276.33B | +74.67% | 3.05% |
| SBAC | -6.61% | $25.65B | +26.32% | 1.76% |
| CL | -6.00% | $74.59B | -4.24% | 2.20% |
Yahoo
UniFirst (UNF) delivered earnings and revenue surprises of +2.36% and -0.36%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
Proto Labs’ first quarter results were well received by the market, as management pointed to growth in its production manufacturing business and improved customer engagement. CEO Rob Bodor emphasized the company’s progress in shifting from a prototyping-focused model, highlighting that customers using both prototyping and production services grew more than 45% in the last year. Meanwhile, stronger marketing efforts and operational adjustments also contributed to sequential revenue growth, despit
Yahoo
Proto Labs, Inc. ( NYSE:PRLB ), is not the largest company out there, but it saw a significant share price rise of 22...
Yahoo
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
Yahoo
Over the last six months, Proto Labs’s shares have sunk to $39.05, producing a disappointing 10.4% loss while the S&P 500 was flat. This may have investors wondering how to approach the situation.
Yahoo
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
